NEOGENOMICS INC — Director's Dealing 2015

May 6, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2015-05-04

Reporting Person: JONES STEVEN C (Executive VP of Finance)
Reporting Person: ASPEN SELECT HEALTHCARE LP (Executive VP of Finance)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-07-01	Common Stock	G	2700	$3.98	Disposed	32157	Indirect
2013-12-24	Common Stock	G	15364	$3.6	Disposed	331251	Direct
2014-12-23	Common Stock	G	20000	$4.13	Disposed	311251	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-05-04	Stock Option (Right to Buy)	$4.78	A	225000	Acquired	2020-05-04	Common Stock (0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	212745	Indirect
Common Stock	3500000	Indirect
Common Stock	50476	Indirect
Common Stock	190000	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrants (Right to Buy)	$1.5	2017-05-03	Common Stock (0)	450000	Direct

Footnotes

F1: Aspen Select Healthcare, LP is a private investment fund. Medical Venture Partners, LLC is the sole general partner of Aspen Select Healthcare, LP, and Mr. Jones is a Managing Member of Medical Venture Partners, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein.

F2: An investment partnership entity controlled by Steven Jones. Mr. Jones disclaims beneficial ownership or such shares except to his pecuniary interests therein.

F3: Such warrants were issued in connection with a consulting agreement, dated 5/3/2010.

F4: On May 4, 2015 Mr. Jones was granted 225,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.